23. July 2018
There are a multitude of sweeteners available to the pharmaceutical scientist. Sweeteners may be broadly grouped into two categories – nutritive and non-nutritive. Nutritive sweeteners delivercalories and as their name suggests, non-nutritive do not. Non-nutritive sweeteners can be further characterized as bulk (sugar alcohols) and high intensity (artificial). Some excipients that are sweet are often incorrectly listed in publications as “sweeteners.” These are excipients used primarily...
17. May 2018
Insofar as pharma M&As are concerned, 2018 is turning out to be a milestone year with more than US$ 170 billion invested in the first quarter alone. While March saw a steep climb in deal values with the Cigna-Express Scripts US$ 67 billion acquisition, April remained significant for Novartis’ renewed interests in gene therapy — the Swiss pharma giant acquired AveXis, a clinical-stage gene therapy company, for US$ 8.7 billion. Novartis retains focus on gene therapy with US$ 8.7 billion...
26. April 2018
Are you a manufacturer of raw materials for the food, nutraceutical or pharmaceutical industry and interested to increase your product performance or functionality? Are topics like Dust free Solubility Protection Taste masking Targeted release Particle size Flowability relevant to you or for the life cycle management of your product? Then come to speak with the experts from IPC Process Center @Vitafoods Geneva Stand T167 - May 15-17, 2018. If not attending just drop us an email. Further...
20. April 2018
Are you looking for a tailored film coating for your product? pharmaexcipients offers the access to film coating experts to put together a tailored coating based on your application and needs in a fast and simple way. Just fill in the questionnaire
26. March 2018
The completed analysis, performed by GlobalData, a data and analytics company, reveals a number of interesting insights. The pharma sector’s 2017 v 2016 year on year performance inevitably created a mixed picture, with only half of the top 25 companies’ market cap achieving double digit growth and five players, Merck US, Celgene, GlaxoSmithKline, Allergan and Shire seeing their market cap fall. However, based on market cap J&J, Roche and Pfizer retained market position among the top...
18. March 2018
This presentation will explain the definition of pharmaceutical excipients. Also, it shows the main regulation institutions and existing regulation. It shows the main roles of pharma excipients as well as the ideal properties of pharma excipients. This first part ends with a short view of the excipient market.
03. March 2018
The year started with big bang M&A deals and was the most active January for deal making in over a decade with Sanofi and Celgene dominating the headlines.
French drugmaker Sanofi started off by announcing it had closed a deal to acquire Biogen spinout Bioverativ, a maker of drugs for hemophilia, for almost US$ 11.6 billion.
20. February 2018
April 30 - May 1, 2018 in Boston, MA Harnessing Scientific Innovations and R&D Efficiency through Refined Sourcing & Procurement Strategies The 2nd Annual Advanced R&D Sourcing & Procurement in Pharma will return to Boston in April! Building on the successful conversations in 2017, we will continue to explore the rapidly transforming R&D procurement space, helping the community to: Understand how best to manage supplier diversity and tail spend Define tactics to handle early...
25. January 2018
Die positive Konjunktur in Europa schlägt auch auf die Chemie- und Pharmaindustrie durch: Ein sattes Umsatzplus und Produktionszuwachs haben in der Chemie zum höchsten Beschäftigungsstand seit 13 Jahren geführt.
15. December 2017
While debt-laden Teva led the deals in September through its disinvestment efforts, the biggest pharma deal in October was also from the world of generics as Amneal decided to merge with Impax.